Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Andrew Kenna
Introduction
Andrew Kenna is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceuticals. With a focus on innovative formulations and treatments, he has been instrumental in advancing medical science.
Latest Patents
Andrew Kenna holds 2 patents related to spray-dried dispersions and pharmaceutical compositions. His latest patents include formulations of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide. These patents disclose the use of these compositions in the treatment of cancer, autoimmune, and inflammatory diseases. Additionally, they provide crystalline forms of the compound that are also useful in these treatments.
Career Highlights
Andrew Kenna is currently associated with Loxo Oncology, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments that can significantly impact patient care and outcomes.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Barbara J Brandhuber and Lauren T Brent. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Andrew Kenna's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of cancer and autoimmune disease treatments. His patents reflect a commitment to improving healthcare through scientific advancements.